Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMPL Impel NeuroPharma > Detailed Quotes

IMPL Impel NeuroPharma

5.120
+0.070+1.39%
Close 10/06 16:00 ET
High
5.270
Open
4.990
Turnover
169.76K
Low
4.990
Pre Close
5.050
Volume
33.36K
Market Cap
121.54M
P/E(TTM)
Loss
52wk High
12.560
Shares
23.74M
P/E(Static)
Loss
52wk Low
4.620
Float Cap
53.63M
Bid/Ask %
0.00%
Historical High
34.750
Shs Float
10.47M
Volume Ratio
0.57
Historical Low
4.620
Dividend TTM
--
Div Yield TTM
--
P/B
31.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.32%
Amplitude
5.55%
Avg Price
5.088
Lot Size
1
Float Cap
53.63M
Bid/Ask %
0.00%
Historical High
34.750
Shs Float
10.47M
Volume Ratio
0.57
Historical Low
4.620
Dividend TTM
--
P/B
31.03
Dividend LFY
--
Turnover Ratio
0.32%
Amplitude
5.55%
Avg Price
5.088
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Impel Pharmaceuticals, Inc. operates as clinical stage biotechnology firm that develops medical devices. It offers intranasal drug treatments for central nervous system (CNS) disorders. The firm product candidates includes TRUDHESA, INP105, and INP107. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.
CEO: Mr. Adrian Adams
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...